*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Johnson & Johnson will pay more than $1 billion to the U.S. and most states to resolve a civil investigation into marketing of ...

J&J to Pay $2.2B Settlement to End Risperdal Probes New Brunswick, N.J.-based Johnson & Johnson has agreed to pay up to $2.2 billion to settle U.S. investigations and lawsuits regarding its marketing ...

Lupin has received approval from the Food and Drug Administration for risperidone for extended-release injectable suspension, 25 mg per vial, 37.5 mg per vial and 50 mg per vial, single-dose vials.

RISPERDAL CONSTA prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.

Following research that indicates a possible link between gynecomastia and use of Risperdal, a law firm says it is continuing to offer legal consultations to those who developed the condition.

The drug is indicated for the treatment of schizophrenia and for additional maintenance treatment of bipolar disorder. Gavaris added, "It highlights our commitment to expanding our portfolio of ...

Pharma major Lupin Ltd on Wednesday said it has received approval from the US health regulator for its generic version of risperidone for extended-release injectable suspension, used in the treatment ...

Johnson & Johnson has agreed to pay $158 million to Texas to settle allegations of Medicaid fraud, according to a news release from the office of Texas Attorney General Greg Abbott. An investigation ...

Three weeks before the latest Risperdal case was tossed out midtrial, one of the jurors initially tasked with evaluating the claims collapsed while a plaintiff's expert was testifying on the stand.

MUMBAI, India and NAPLES, Fla., Nov. 14, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of ...

PARSIPPANY, N.J. & TEL AVIV, Israel & PARIS--(BUSINESS WIRE)-- Regulatory News: Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell ...